Interview with the CEO and the Chairman: Abivax (OTCMKTS:AAVXF)

Healthcare >> CEO Interviews >> September 22, 2020

Prof. Hartmut J. Ehrlich, M.D., is Chief Executive Officer of Abivax. Prof. Ehrlich is a physician with 30 years of experience in academia and in the biopharmaceutical industry, 20 of which were in product development at Baxter and Sandoz (now Novartis). He has lived and worked in the United States (Eli Lilly and Indiana University, Dept. of Medicine), the Netherlands (Central Laboratory of the Dutch Red Cross), Germany (Max Planck Foundation, Sandoz, Baxter), Switzerland (Sandoz), Austria (Baxter) and France (Abivax). Over the seven years before joining Abivax, Prof. Ehrlich, as Head of Global R&D, successfully built and advanced Baxter BioScience’s R&D portfolio with over 50 programs in preclinical and clinical development. He drove the regulatory approval of key biologics in the specialty areas of hemophilia, thrombosis, immunology, neurology, oncology, biosurgery and vaccines, thereby bringing novel therapies to patients with substantial medical needs. Prof. Ehrlich has authored and co-authored over 120 peer-reviewed articles and book chapters. In 2011, Prof. Ehrlich was named “Professor” by the Austrian President and the Austrian Minister for Science and Research, and he received the title of “Adjunct Professor” of the Danube University Krems, Lower Austria in 2013. Profile

Philippe Pouletty, M.D., is Founder and Chairman of Abivax and Co-founder and CEO of Truffle Capital. Dr. Pouletty has a strong background in Europe and the United States (including Silicon Valley) and is a pioneer in the biotechnology and medical devices sector. As an entrepreneur, he founded/co-founded among others: Carmat, Deinove, Abivax, Pharnext, Vexim — Truffle portfolio companies. As an inventor, Dr. Pouletty has filed 32 patents, one of which is the second-highest revenue generator in life sciences for Stanford University, earning him membership in Stanford’s prestigious Invention Hall of Fame in 2012. Dr. Pouletty was Chairman of France Biotech from 2001 to 2009, and has held the title of Honorary Chairman since 2009. He conceived the Jeune Entreprise Innovante (JEI) program to boost the development of young and innovative companies in France. Philippe Pouletty is a medical doctor, former resident in haematology and immunology in Parisian hospitals, and was a postdoctoral researcher (1986-1988) at Stanford University. He was the 1999 winner of the American Liver Foundation award. Dr. Pouletty has been awarded Chevalier de la Légion d’Honneur. Profile

Word count: 2,287

TWST: Could you explain about the company and its background?

Dr. Pouletty: Abivax was founded by Truffle Capital, my fund in Paris, in 2013

Join for free to read a longer excerpt or purchase this article

Interview with the CEO and the Chairman: Abivax (OTCMKTS:AAVXF)

Top Company Interviews

CEO INTERVIEWS

SECTOR ROUNDTABLES

MONEY MANAGER INTERVIEWS

ANALYST INTERVIEWS

Interview with the CEO and the Chairman: Abivax (OTCMKTS:AAVXF)

Top Company Interviews

Register for a Free Account to gain greater access to The Wall Street Transcript right now

CEO INTERVIEWS

SECTOR ROUNDTABLES

MONEY MANAGER INTERVIEWS

ANALYST INTERVIEWS